SMT Won the Italian National CONSIP 2-Year Tender to Supply Hydra TAVI in All Italian Hospitals
08.08.2024 - 15:08:05
(Sahajanand Medical Technologies Ltd.) is proud to announce its classification in the Italian national CONSIP 2-year tender to supply its state-of-the-art Hydra Transcatheter Aortic Valve Implantation (TAVI) devices to all hospitals across Italy. This significant milestone marks a pivotal moment in SMT’s mission to enhance patient care through innovative medical technologies.
The Hydra TAVI device, an innovative and highly deliverable aortic valve with optimal radial strength and supra-annular valve positioning, is now available for procurement by all National Health Service (NHS) hospitals in Italy. This classification ensures that Italian healthcare providers have access to advanced solutions for treating aortic stenosis, thereby improving patient outcomes and operational efficiencies.
Commenting on this achievement, Gaurav Goel, Global Head of the Structural Heart Division at SMT, said, “We are thrilled to be recognized in the CONSIP tender, which underscores the quality and effectiveness of our Hydra TAVI technology. This opportunity allows us to partner with healthcare providers across Italy to deliver life-saving solutions and enhance the standard of care for patients with aortic stenosis. SMT remains committed to innovation and excellence in the field of structural heart disease.”
Gennaro Broya de Lucia, Distributor Manager Europe for SMT, added, “Being classified in the CONSIP tender is a testament to the dedication and hard work of our entire team. Eukon, our national Italian SMT importer, has been instrumental in this achievement. This collaboration will undoubtedly contribute to meeting the procurement needs of the NHS, ensuring that Italian hospitals are well-equipped with the latest in medical technology.”
The value-based procurement approach of the NHS emphasizes cost-efficiency and high-quality patient care, aligning perfectly with SMT’s commitment to delivering cutting-edge medical solutions at competitive prices. This tender not only reinforces SMT’s position as a leader in the medical technology sector but also highlights the importance of providing healthcare professionals with the best tools to address critical health challenges.
*CONSIP is an Italian state-owned company that provides frameworks and consultation for the procurement of public goods and services.
The Hydra TAVI device, an innovative and highly deliverable aortic valve with optimal radial strength and supra-annular valve positioning, is now available for procurement by all National Health Service (NHS) hospitals in Italy. This classification ensures that Italian healthcare providers have access to advanced solutions for treating aortic stenosis, thereby improving patient outcomes and operational efficiencies.
Commenting on this achievement, Gaurav Goel, Global Head of the Structural Heart Division at SMT, said, “We are thrilled to be recognized in the CONSIP tender, which underscores the quality and effectiveness of our Hydra TAVI technology. This opportunity allows us to partner with healthcare providers across Italy to deliver life-saving solutions and enhance the standard of care for patients with aortic stenosis. SMT remains committed to innovation and excellence in the field of structural heart disease.”
Gennaro Broya de Lucia, Distributor Manager Europe for SMT, added, “Being classified in the CONSIP tender is a testament to the dedication and hard work of our entire team. Eukon, our national Italian SMT importer, has been instrumental in this achievement. This collaboration will undoubtedly contribute to meeting the procurement needs of the NHS, ensuring that Italian hospitals are well-equipped with the latest in medical technology.”
The value-based procurement approach of the NHS emphasizes cost-efficiency and high-quality patient care, aligning perfectly with SMT’s commitment to delivering cutting-edge medical solutions at competitive prices. This tender not only reinforces SMT’s position as a leader in the medical technology sector but also highlights the importance of providing healthcare professionals with the best tools to address critical health challenges.
*CONSIP is an Italian state-owned company that provides frameworks and consultation for the procurement of public goods and services.
About SMT
SMT is a global medical device company committed to make advanced medical technologies accessible to everyone around the world. With presence in 80 countries, SMT has achieved recognitions from the Ministry of Health Sciences & Technologies for its tremendous contributions in the field of coronary healthcare. SMT also pioneered the introduction of biodegradable polymers in the cardiovascular segment. SMT will continue the journey to heal hearts around the world by creating healthcare future promising for everyone.
About Hydra
Hydra is a self-expandable nitinol stent frame with three bovine pericardium leaflets in a supra-annular position to provide large effective orifice area and low transvalvular pressure gradient. A high sealing skirt at the inflow part of the stent frame mitigates paravalvular leak. The contoured non-flared inflow part of the stent frame aims to reduce interference with the conduction system and thereby new conduction abnormalities.
SMT is a global medical device company committed to make advanced medical technologies accessible to everyone around the world. With presence in 80 countries, SMT has achieved recognitions from the Ministry of Health Sciences & Technologies for its tremendous contributions in the field of coronary healthcare. SMT also pioneered the introduction of biodegradable polymers in the cardiovascular segment. SMT will continue the journey to heal hearts around the world by creating healthcare future promising for everyone.
About Hydra
Hydra is a self-expandable nitinol stent frame with three bovine pericardium leaflets in a supra-annular position to provide large effective orifice area and low transvalvular pressure gradient. A high sealing skirt at the inflow part of the stent frame mitigates paravalvular leak. The contoured non-flared inflow part of the stent frame aims to reduce interference with the conduction system and thereby new conduction abnormalities.
